207 related articles for article (PubMed ID: 30127783)
21. SP-D and regulation of the pulmonary innate immune system in allergic airway changes.
Forbes LR; Haczku A
Clin Exp Allergy; 2010 Apr; 40(4):547-62. PubMed ID: 20447075
[TBL] [Abstract][Full Text] [Related]
22. Surfactant proteins SP-A and SP-D in human health and disease.
Kishore U; Bernal AL; Kamran MF; Saxena S; Singh M; Sarma PU; Madan T; Chakraborty T
Arch Immunol Ther Exp (Warsz); 2005; 53(5):399-417. PubMed ID: 16314824
[TBL] [Abstract][Full Text] [Related]
23. Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.
Chen YT; Hsu M; Lee P; Shin SJ; Mhawech-Fauceglia P; Odunsi K; Altorki NK; Song CJ; Jin BQ; Simpson AJ; Old LJ
Int J Cancer; 2009 Jun; 124(12):2893-8. PubMed ID: 19296537
[TBL] [Abstract][Full Text] [Related]
24. Surfactant Proteins SP-A and SP-D Ameliorate Pneumonia Severity and Intestinal Injury in a Murine Model of Staphylococcus Aureus Pneumonia.
Du X; Meng Q; Sharif A; Abdel-Razek OA; Zhang L; Wang G; Cooney RN
Shock; 2016 Aug; 46(2):164-72. PubMed ID: 26849628
[TBL] [Abstract][Full Text] [Related]
25. Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway.
Kamio K; Usuki J; Azuma A; Matsuda K; Ishii T; Inomata M; Hayashi H; Kokuho N; Fujita K; Saito Y; Miya T; Gemma A
Pulm Pharmacol Ther; 2015 Jun; 32():29-36. PubMed ID: 25843005
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Complement Properdin in Cancer.
Mangogna A; Varghese PM; Agostinis C; Alrokayan SH; Khan HA; Stover CM; Belmonte B; Martorana A; Ricci G; Bulla R; Kishore U
Front Immunol; 2020; 11():614980. PubMed ID: 33542722
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis.
Cao T; Pan W; Sun X; Shen H
J Ovarian Res; 2019 Oct; 12(1):101. PubMed ID: 31656201
[TBL] [Abstract][Full Text] [Related]
28. Prognostic values of S100 family mRNA expression in ovarian cancer.
Ma N; Zhu L; Yang L; Cui Y; Zhan Y
Cancer Biomark; 2019; 25(1):67-78. PubMed ID: 31033462
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effects of recombinant forms of full-length and truncated human surfactant protein D in a murine model of invasive pulmonary aspergillosis.
Singh M; Madan T; Waters P; Sonar S; Singh SK; Kamran MF; Bernal AL; Sarma PU; Singh VK; Crouch EC; Kishore U
Mol Immunol; 2009 Jul; 46(11-12):2363-9. PubMed ID: 19403176
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary surfactant protein SP-D opsonises carbon nanotubes and augments their phagocytosis and subsequent pro-inflammatory immune response.
Pondman KM; Paudyal B; Sim RB; Kaur A; Kouser L; Tsolaki AG; Jones LA; Salvador-Morales C; Khan HA; Ten Haken B; Stenbeck G; Kishore U
Nanoscale; 2017 Jan; 9(3):1097-1109. PubMed ID: 27991644
[TBL] [Abstract][Full Text] [Related]
31. The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation.
Wang JY; Reid KB
Immunobiology; 2007; 212(4-5):417-25. PubMed ID: 17544824
[TBL] [Abstract][Full Text] [Related]
32. Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers.
Liu X; Xu Q; Li Z; Xiong B
Sci Rep; 2020 Nov; 10(1):20795. PubMed ID: 33247170
[TBL] [Abstract][Full Text] [Related]
33. A membrane-type surfactant protein D (SP-D) suppresses macrophage-mediated cytotoxicity in swine endothelial cells.
Jiaravuthisan P; Maeda A; Takakura C; Wang HT; Sakai R; Shabri AM; Lo PC; Matsuura R; Kodama T; Eguchi H; Okuyama H; Miyagawa S
Transpl Immunol; 2018 Apr; 47():44-48. PubMed ID: 29425774
[TBL] [Abstract][Full Text] [Related]
34. Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas.
Mangogna A; Agostinis C; Bonazza D; Belmonte B; Zacchi P; Zito G; Romano A; Zanconati F; Ricci G; Kishore U; Bulla R
Front Immunol; 2019; 10():865. PubMed ID: 31130944
[TBL] [Abstract][Full Text] [Related]
35. Surfactant protein D in human lung diseases.
Hartl D; Griese M
Eur J Clin Invest; 2006 Jun; 36(6):423-35. PubMed ID: 16684127
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.
Deng Q; Yang H; Lin Y; Qiu Y; Gu X; He P; Zhao M; Wang H; Xu Y; Lin Y; Jiang J; He J; Zhou JX
Int J Clin Exp Pathol; 2014; 7(12):8312-21. PubMed ID: 25674197
[TBL] [Abstract][Full Text] [Related]
37. Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β.
Ogawa H; Ledford JG; Mukherjee S; Aono Y; Nishioka Y; Lee JJ; Izumi K; Hollingsworth JW
Respir Res; 2014 Nov; 15(1):143. PubMed ID: 25472740
[TBL] [Abstract][Full Text] [Related]
38. Protein-Protein Interaction between Surfactant Protein D and DC-SIGN
Dodagatta-Marri E; Mitchell DA; Pandit H; Sonawani A; Murugaiah V; Idicula-Thomas S; Nal B; Al-Mozaini MM; Kaur A; Madan T; Kishore U
Front Immunol; 2017; 8():834. PubMed ID: 28824609
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus.
Madan T; Reid KB; Singh M; Sarma PU; Kishore U
J Immunol; 2005 Jun; 174(11):6943-54. PubMed ID: 15905537
[TBL] [Abstract][Full Text] [Related]
40. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity.
Sano H; Kuroki Y
Mol Immunol; 2005 Feb; 42(3):279-87. PubMed ID: 15589315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
